Genetics and molecular biology: HDL plasticity and diversity of functions. by Rütti, S. & Widmann, C.
  
Serveur Académique Lausannois SERVAL serval.unil.ch 
Author Manuscript 
Faculty of Biology and Medicine Publication 
This paper has been peer-reviewed but dos not include the final publisher 
proof-corrections or journal pagination. 
Published in final edited form as:  
 
In the absence of a copyright statement, users should assume that standard copyright protection applies, unless the article contains 
an explicit statement to the contrary. In case of doubt, contact the journal publisher to verify the copyright status of an article. 
 
Title: Genetics and molecular biology: HDL plasticity and diversity of 
functions. 
Authors: Rütti S, Widmann C 
Journal: Current opinion in lipidology 
Year: 2015 Dec 
Volume: 26 
Issue: 6 
Pages: 596-7 
DOI: 10.1097/MOL.0000000000000242 
 
Genetics and molecular biology: HDL plasticity and diversity of functions 
Sabine Rütti and Christian Widmann 
 
Department of Physiology, Lausanne University, Switzerland. 
 
Word counts: 596 
 
Address correspondence: Christian Widmann, Department of Physiology, Rue du 
Bugnon 7, 1005 Lausanne, Switzerland, Phone: +41 21 692 5123, Fax: +41 21 692 
5505, E-mail: Christian.Widmann@unil.ch. 
  
It has become clear in recent years that one should not consider HDLs as a homogenous 
entity when studying their functions. It is now indeed recognized and well documented that 
the HDL pool in the blood is made of a variety of HDL particles that differ in terms of 
structure, composition and signaling molecules they carry. More than 80 proteins and 
peptides and more than 200 lipid species have been detected on HDLs [1]. However, a 
single HDL particle only carry a distinct subset of these molecules. For example, less than 
10% of HDL particles carry the bio-active sphingosine-1-phosphate (S1P) lipid [1]. The 
diversity in the composition of HDLs can potentially explain the variety of their functions 
ranging from reverse cholesterol transport to antioxidative, anti-inflammatory and 
cytoprotective activities (reviewed recently in [2]) and [3]). 
HDL particles are more plastic and dynamic than initially thought as recently highlighted by 
O’Neill and colleagues [4] in their study on patients with periodontitis. This human model is of 
interest because it involves a low-grade inflammation systemic status developing from a local 
inflammation site (the teeth). The etiology of the inflammation is therefore somehow simpler 
than what is seen in more complex diseases such as diabetes or the metabolic syndrome. 
Moreover, this model allows researchers to study the impact of low-grade inflammation in 
individuals that serve as their own controls after periodontitis is treated. In this study, 
periodontitis led to disturbed HDL vascular functions such as diminished paraoxonase 
activity and reduced ability to induce NO production by endothelial cells. Intriguingly, the 
cholesterol extraction capacity of HDLs was not affected by periodontitis, suggesting that 
only a subset of HDL functions and activities are affected by low-grade inflammation. While 
this study is in line with others (see [5-7] for recent publications) that showed disease-
induced alterations in HDL functions, its salient point is that low-grade inflammation-
associated perturbations in HDL functions and composition could be fully normalized with the 
resolution of the disease. Hence, HDLs are very plastic particles whose functions are 
dynamically regulated by transition between healthy and disease states. 
Two recent studies by the group of Timothy Hla [8;9] demonstrated the importance of the 
structure and molecules that carry S1P in the responses elicited by this lipid in cells and 
tissues. In the blood, about two third of the S1P molecules are bound to ApoM, an 
apolipoprotein present in about 10% of HDL particles [1], while the remaining molecules are 
associated with albumin. HDL-S1P was shown to bind to the S1P1 receptor on endothelial 
cells and to activate a protective anti-inflammatory and anti-atherosclerotic signals in the 
vasculature [8]. Surprisingly, S1P bound to albumin did not generate these protective 
responses, despite being able to activate S1P1. The resolution of this conundrum came 
through detailed investigation of the signaling pathway activated by albumin-S1P and HDL-
S1P: at similar S1P concentrations (1-2 µM), both albumin-S1P and HDL-S1P stimulated the 
MAPK pathway efficiently but albumin-S1P triggered greater Gi activation and receptor 
endocytosis, whereas only HDL-S1P induced the formation of a S1P1-β-arrestin-2 complex 
that attenuated pro-inflammatory cytokine signaling. In a different experimental system, the 
same group reported that HDL-S1P, but not albumin-S1P, kept in check lymphopoiesis and, 
in a mouse model of autoimmune encephalitis, restrained the development of self-reacting 
lymphocytes [9]. These two studies open the possibility that ApoM-containing HDL particles 
“present” S1P to S1P receptors in a manner different than when S1P is carried by other 
carriers. As suggested by the authors, HDL-S1P may in fact act as a biased agonist for S1P 
receptors. How this is structurally and mechanistically brought about will now need to be 
characterized. 
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Apolipoprotein A1, one of the major protein present in HDL particles, has long been 
recognized as having anti-inflammatory and anti-apoptotic properties. This study shows for 
the first time that the type of phospholipid used to reconstitute HDL particles from ApoA1 has 
significant influence on the reconstituted HDL (rHDL)-mediated protective effects. Hence, the 
phospholipids present in the “membrane” of HDLs particles are not just fulfilling a structural 
role in HDLs but also actively participate in the biological functions of the particles. 
 
 
